Clinical Trials Browser

Phase 2 × sintilimab × Genitourinary × Clear all

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

Sintilimab in FH-deficient Renal Cell Carcinoma